Welcome to LookChem.com Sign In|Join Free

CAS

  • or
Benzyl 4-pentenoate is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

113882-48-7 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 113882-48-7 Structure
  • Basic information

    1. Product Name: Benzyl 4-pentenoate
    2. Synonyms: 4-Pentenoic acid phenylmethyl ester;Benzyl 4-pentenoate;Pent-4-enoic acid benzyl ester;Benzyl pent-4-enoate
    3. CAS NO:113882-48-7
    4. Molecular Formula: C12H14O2
    5. Molecular Weight: 190.23836
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 113882-48-7.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 247℃
    3. Flash Point: 97℃
    4. Appearance: /
    5. Density: 1.018
    6. Refractive Index: N/A
    7. Storage Temp.: Amber Vial, Refrigerator, Under inert atmosphere
    8. Solubility: Chloroform (Slightly)
    9. CAS DataBase Reference: Benzyl 4-pentenoate(CAS DataBase Reference)
    10. NIST Chemistry Reference: Benzyl 4-pentenoate(113882-48-7)
    11. EPA Substance Registry System: Benzyl 4-pentenoate(113882-48-7)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 113882-48-7(Hazardous Substances Data)

113882-48-7 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 113882-48-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,3,8,8 and 2 respectively; the second part has 2 digits, 4 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 113882-48:
(8*1)+(7*1)+(6*3)+(5*8)+(4*8)+(3*2)+(2*4)+(1*8)=127
127 % 10 = 7
So 113882-48-7 is a valid CAS Registry Number.

113882-48-7Relevant articles and documents

Visible-Light Photoredox-Catalyzed α-Allylation of α-Bromocarbonyl Compounds Using Allyltrimethylsilane

Gontala, Arjun,Jang, Gwang Seok,Woo, Sang Kook

, p. 506 - 509 (2021)

The development of a greener allylation reagent for α-allylation of carbonyl compounds is of great necessity. Here we present allyltrimethylsilane as a novel allylation reagent in the photoredox-catalyzed α-allylation of carbonyl compounds such as ketones, esters, and amides. The reaction process shows good functional group tolerance and generates a good yield of the product. The reaction mechanism is a radical-mediated reaction by photo-induced single electron transfer.

Triethylborane-Induced Radical Allylation Reaction with Zirconocene-Olefin Complex

Hirano, Koji,Fujita, Kazuya,Shinokubo, Hiroshi,Oshima, Koichiro

, p. 593 - 595 (2004)

(Matrix presented) Allylzirconium reagents are effective for radical allylation of α-halo carbonyl compounds. The key steps would be homolytic cleavage of the zirconium-carbon bond and halogen abstraction by the resulting Cp2ZrCI(III). Zirconoc

Triethylborane-induced radical allylation of α-halo carbonyl compounds with allylgallium reagent in aqueous media

Usugi, Shin-ichi,Yorimitsu, Hideki,Oshima, Koichiro

, p. 4535 - 4538 (2001)

An allylgallium reagent is found to be effective for radical allylation of α-iodo or α-bromo carbonyl compounds. Treatment of benzyl bromoacetate with allylgallium, prepared from allylmagnesium chloride and gallium trichloride, in the presence of triethylborane in THF provided benzyl 4-pentenoate in good yield. The addition of water as a cosolvent improved the yields of allylated products. It was revealed that the allylgallium species resists immediate decomposition on exposure to water.

Diethylzinc-Mediated Radical 1,2-Addition of Alkenes and Alkynes

Li, Xin,He, Songtao,Song, Qiuling

supporting information, p. 2994 - 2999 (2021/05/04)

A novel diethylzinc-mediated radical 1,2-addition of perfluoroalkyl iodides to unactivated alkenes and alkynes is presented, which demonstrates a novel way to generate an ethyl difluoroacetate radical. This method is highly efficient and gives full conversions of the substrates, high yields of the products, and negligible byproducts and requires no column chromatography purifications. The mild conditions enable this protocol to exhibit excellent functional group compatibility.

CYCLOSPORINE COMPOSITIONS AND METHODS OF USE

-

Paragraph 0140-0141, (2020/03/15)

Disclosed herein are cyclosporine compounds and methods for use in the treatment or prevention of neutrophil-mediated inflammation, wherein the compounds inhibit the activity of MRP2 and FPR1.

Straightforward synthesis of functionalized (E)-3-acylacrylic acids

Sivák, Ivan,Václav, Jakub,Berke?, Du?an,Kolarovi?, Andrej

supporting information, p. 8871 - 8875 (2015/11/02)

An experimentally simple, mild and straightforward synthetic route towards diversely functionalized (E)-3-acylacrylic acids is described, with Horner-Wadsworth-Emmons (HWE) reaction as the key step. The substrate scope and limitations of the HWE reaction were investigated with a range of β-ketophosphonates. Glyoxylic acid monohydrate was demonstrated to be fully compatible with the HWE reaction conditions, thus avoiding a troublesome hydrolysis of the corresponding 3-acylacrylates in the last step and providing a valuable synthetic shortcut.

METHODS OF SYNTHESIZING SUBSTITUTED PURINE COMPOUNDS

-

Paragraph 0618; 0619; 0620, (2014/10/04)

The present invention provides an efficient process for the synthesis of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)-5-((((1r,3S)-3-(2-(5-(tert-butyl)-1H- benzo[d]imidazol-2-yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofiiran-3,4-diol and hydrates thereof and methods for treating disorders in which DOTl -mediated protein methylation plays a part, such as cancer and neurological disorders, by administering these compounds and pharmaceutical compositions to subjects in need thereof. The present invention also provides novel crystalline forms of (2R,3R,4S,5R)-2-(6-amino-9H-purin-9-yl)- 5 -(((( 1 r,3 S)-3 -(2-(5 -(tert-butyl)- 1 H-benzo[d] imidazol-2- yl)ethyl)cyclobutyl)(isopropyl)amino)methyl)tetrahydrofuran-3,4-diol and hydrates thereof (Form A, Form B, and Form C), characterized by a unique X-ray diffraction pattern and Differential Scanning Calorimetry profile, as well as a unique crystalline structure.

[Cu(dap)2Cl] as an efficient visible-light-driven photoredox catalyst in carbon-carbon bond-forming reactions

Pirtsch, Michael,Paria, Suva,Matsuno, Taisuke,Isobe, Hiroyuki,Reiser, Oliver

supporting information; experimental part, p. 7336 - 7340 (2012/09/08)

Copper sees the light of day: [Cu(dap)2Cl] proved to be an excellent photoredox catalyst for atom-transfer radical addition reactions, as well as for allylation reactions (see scheme), providing an attractive alternative to commonly used iridium- and ruthenium-based catalysts. Copyright

Potassium Channel Modulators

-

Page/Page column 38, (2012/05/21)

Disclosed herein are KCNQ potassium channels modulators of formula (I) wherein R1, R2, R3, R4, and R5 are as defined in the specification. Compositions comprising such compounds; and methods for treating conditions and disorders using such compounds and compositions are also described.

Targeting the heat shock protein 90 dimer with dimeric inhibitors

Kusuma, Bhaskar Reddy,Peterson, Laura B.,Zhao, Huiping,Vielhauer, George,Holzbeierlein, Jeffrey,Blagg, Brian S. J.

experimental part, p. 6234 - 6253 (2011/10/31)

The design, synthesis, and biological evaluation of conformationally constrained coumermycin A1 analogues are reported. Compounds were evaluated against both breast cancer (SKBr3 and MCF7) and prostate cancer (PC3 mm2, A549, and HT29) cell lines. Non-noviosylated coumermycin A1 analogues that manifest potent antiproliferative activity resulting from Hsp90 inhibition are provided, wherein replacement of the stereochemically complex noviose sugar with readily available piperidine rings resulted in ü100 fold increase in antiproliferative activities as compared to coumermycin A1, producing small molecule Hsp90 inhibitors that exhibit nanomolar activities.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 113882-48-7